We Did Not Know That Prostate Cancer

Prostate cancer is the most frequently diagnosed skin cancer cancer not exceeded most lung cancer affecting all men and followed by colorectal cancer.

Statistically, 80 percent of prostate cancers occur in men over 65. As men age the prostate may develop problems.

We did not know that the man is 33% more likely to develop prostate cancer than a woman is to get breast cancer.

In 2004, an estimated 234,000 new cases of prostate cancer diagnosed in the United States. This makes it the most common cancer in American men, next to skin cancer. are expected more than 27,000 deaths from prostate cancer occur each year.

While in the UK, around 35,000 men are diagnosed and about 10,000 men die of prostate cancer each year. Today, about two million men fight prostate cancer, and over the next decade as baby boomer men reach the target ripen age for prostate cancer, the most three million will be required to join battle. What is the prostate?

The tube that carries urine (the urethra) through the prostate. In older men, the part of the prostate surrounds the urethra can continue to grow. This causes BPH (benign prostatic hyperplasia) that cause difficulty urinating. BPH is a problem that must be treated, but not cancer.

What is prostate cancer?

Normally, cells grow, divide and die. Instead of dying, these abnormal cells clump together to form tumors. Prostate cancer is the abnormal cells grow out of control nodes or formation of small projections (tissue overgrowth) on the surface of the prostate gland. In some cases, the tissue is benign overgrowth of the prostate gland and this condition is called benign prostatic hyperplasia (BPH). Other times, the abnormal cancer cells characterize the tissue overgrowth, which is called a cancer or a malignant tumor of the prostate.

As its proximity to the bladder, prostate disorders can interfere with urination and causing bladder or kidney. Although over 70% of all cases of prostate cancer are diagnosed in men over 65 years, doctors recommend that all men over 50 should have a PSA test and a rectal exam. The same is true if you have afamily history of prostate cancer.

One-third of older than 50 men have cancerous cells in their prostate and almost all men over 80 years have a small prostate cancer area. In most men, these cancers grow very slowly, especially in older men, and will never cause problems. Prostate cancer often causes no symptoms for years. Symptoms include:

    U
rinary problems:
    
Pain in the region, hips or upper thighs Pelvic
    
Not being able to urinate
    Feeling that your bladder does not empty
    Having trouble starting or stopping the urine flow
    Problems with urinary urgency and difficulty from
    F
requent urination, especially at night
    
Weak flow of urine
    
Urine flow that starts and stops
    
Pain or burning during urination
    Difficulty having an erection
    Pain in ejaculation
    G
enital pain
    
Blood in urine or semen

Note: Other health problems such as urinary tract infection or inflammation; bladder or kidney stones problems can cause exactly the same symptoms. A
lways the risk factors associated with prostate cancer include:

    
Age: After 50 years, the risk of developing prostate cancer is higher. More than 80 percent of all prostate cancers occur in men aged 65 and over.
    Race: African American men have a 60% higher risk of prostate cancer than white men, including Hispanic men
    Race: more common in North America and northwestern Europe and occurs less frequently in Asia, Africa, Central America and South America.
    Having a family history of prostate cancer, a parent or sibling with the disease doubles the risk of a man developing. The man whose brother had a prostate cancer are 4.5 times higher risk of prostate cancer and 2.5 times higher if his father had prostate cancer.
    Studies show lycopene-rich diet (found in higher levels in colorful fruits and vegetables), selenium, goji, broccoli and turmeric can reduce the risk of developing prostate cancer.
    Exercise: Maintain a healthy weight and regular physical activity can reduce the risk of prostate cancer.
    How prostate cancer is detected?

There are three common methods of prostate cancer screening:

    Digital rectal examination (DRE) Digital rectal examination as part of an annual physical examination in men aged 50 (men and young people who are at increased risk) aged. The blood test for prostate specific antigen (PSA) The PSA is a blood test that measures a protein in cells of the prostate gland. The American Cancer Society recommends the test to be performed annually for men 50 and older, and for younger men at high risk for prostate cancer.

The higher level of PSA, the more likely there are prostate cancer.

The test should not be validated by biopsy as the PSA test can not be used as an infallible test for prostate cancer:

    2 3 males with PSA levels do not have cancer cells in the prostate biopsy.
    1 in 5 men with prostate cancer have a normal PSA result.
    If the biopsy shows cancer, other tests are done to see if it has spread to other organs:

    Blood tests- can be taken to see if the cancer has
    Bone scan to determine whether the cancer has spread to the bone
    CT scan of a series of pelvic radiographic images or abdomen, often used to determine the general signs of disease
    The chest X-ray to determine if cancer has spread to the lungs
    The magnetic resonance imaging, MRI to detect cancer in the lymph nodes and other internal organs,

What is the usual treatment for prostate cancer?

There are several treatments for prostate cancer, including surgery, radiotherapy and various types of medication. It blocks the action of testosterone, a sex hormone that prostate cancers need to grow.

Three treatment options are generally accepted for men with localized
prostate:

   Radical prostatectomy: A surgical procedure to remove the entire prostate gland and surrounding tissue.

   Radiotherapy: Using energy to the prostate gland with external radiotherapy. Patients with cancer at high risk prostate are candidates for hormonal therapy to standard radiation therapy.

    Active surveillance can be a recommended option for patients with prostate cancer at an early stage, especially those with low-grade tumors with only a small amount of cancer seen in the biopsy.

Load disqus comments

0 komentar